Kenneth H. Gabbay

13.2k citations

116 papers · 11.0k indexed · 4 hit papers · h-index 55

Cell Biology top 0.1%
Molecular Biology top 2%
Endocrinology, Diabetes and Metabolism top 0.2%
Physiology top 1%
Surgery top 2%

Co-authors: Kurt M. Bohren Paul M. Gallop H. Franklin Bunn David Owerbach Christine Balko Ralf Steinmetz David N. Haney Bryant P. Bullock
Topics: Aldose Reductase and Taurine (46 papers)Pancreatic function and diabetes (30 papers)Prenatal Substance Exposure Effects (21 papers)
Cited by: Cell Biology Endocrinology, Diabetes and Metabolism Clinical Biochemistry
Journals: Nature Science New England Journal of Medicine
Partner nations: United States Switzerland Sweden

In The Last Decade

Kenneth H. Gabbay

116 papers receiving 10.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Glycosylation of Hemoglobin: Relevance to Diabetes Mellitus

1978 740 citations Kenneth H. Gabbay et al. profile →
The Sorbitol Pathway and the Complications of Diabetes

1973 638 citations Kenneth H. Gabbay et al. profile →
The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo.

1976 448 citations Kenneth H. Gabbay et al. profile →
Glycosylated Hemoglobins and Long-Term Blood Glucose Control in Diabetes Mellitus

1977 432 citations Kenneth H. Gabbay et al. The Journal of Clinical Endocrinology & Metabolism profile →

Peers

Countries citing papers authored by Kenneth H. Gabbay

Since Specialization

Citations

This map shows the geographic impact of Kenneth H. Gabbay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth H. Gabbay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth H. Gabbay more than expected).

Fields of papers citing papers by Kenneth H. Gabbay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth H. Gabbay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth H. Gabbay. The network helps show where Kenneth H. Gabbay may publish in the future.

Co-authorship network of co-authors of Kenneth H. Gabbay

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth H. Gabbay. A scholar is included among the top collaborators of Kenneth H. Gabbay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth H. Gabbay. Kenneth H. Gabbay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Aldose reductase modulates acute activation of mesenchymal markers via the β-catenin pathway during cardiac ischemia-reperfusion 2017 ·PLoS ONE ·Devi Thiagarajan,(unknown),Gopalkrishna Sreejit,Radha Ananthakrishnan,Nosirudeen Quadri,Qing Li,Ann Marie Schmidt,Kenneth H. Gabbay,Ravichandran Ramasamy	3
2	Affinity chromatography of native SUMO proteins using His-tagged recombinant UBC9 bound to Co2+-charged talon resin 2007 ·Protein Expression and Purification ·Kurt M. Bohren,Kenneth H. Gabbay,David Owerbach	21
3	A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation 2005 ·Biochemical and Biophysical Research Communications ·David Owerbach,Eileen McKay,Edward T.H. Yeh,Kenneth H. Gabbay,Kurt M. Bohren	199
4	The structure of Apo R268A human aldose reductase: Hinges and latches that control the kinetic mechanism 2005 ·Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ·Kurt M. Bohren,June M. Brownlee,(unknown),Kenneth H. Gabbay,David H. T. Harrison	16
5	Cyclosporine A Inhibits the Adaptive Responses to Hypertonicity 2001 ·Journal of the American Society of Nephrology ·David Sheikh‐Hamad,(unknown),Yeong Jin Choi,Luan D. Truong,Christi Wideman,(unknown),Kenneth H. Gabbay	41
6	Characterization of the Human Aldehyde Reductase Gene and Promoter 1999 ·Genomics ·Oleg A. Barski,Kenneth H. Gabbay,Kurt M. Bohren	31
7	Osmotic Response Element Enhancer Activity 1999 ·Journal of Biological Chemistry ·(unknown),Kenneth H. Gabbay,Kurt M. Bohren,David Sheikh‐Hamad	78
8	Linkage Analyses in Type I Diabetes mellitus Using CASPAR, a Software and Statistical Program for Conditional Analysis of Polygenic Diseases 1997 ·Human Heredity ·Jeremy Buhler,David Owerbach,(unknown),Marek Kimmel,Kenneth H. Gabbay	16
9	Characterization of an Element Resembling an Androgen Response Element (are) in the Human Aldose Reductase Promoter 1996 ·Advances in experimental medicine and biology ·(unknown),Kurt M. Bohren,Kenneth H. Gabbay	3
10	Mechanism of Human Aldehyde Reductase: Characterization of the Active Site Pocket 1995 ·Biochemistry ·Oleg A. Barski,Kenneth H. Gabbay,Charles E. Grimshaw,Kurt M. Bohren	110
11	Expression, Crystallization and Preliminary Crystallographic Analysis of Human Carbonyl Reductase 1994 ·Journal of Molecular Biology ·Kurt M. Bohren,(unknown),David H. T. Harrison,Dagmar Ringe,Gregory A. Petsko,Kenneth H. Gabbay	20
12	Mechanism of Aldose Reductase Inhibition: Binding of NADP+/NADPH and Alrestatin-like Inhibitors 1994 ·Biochemistry ·Torsten Ehrig,Kurt M. Bohren,Franklyn G. Prendergast,Kenneth H. Gabbay	73
13	An Anion Binding Site in Human Aldose Reductase: Mechanistic Implications for the Binding of Citrate, Cacodylate, and Glucose 6-Phosphate 1994 ·Biochemistry ·David H. T. Harrison,Kurt M. Bohren,Dagmar Ringe,Gregory A. Petsko,Kenneth H. Gabbay	128
14	CYS298 is Responsible for Reversible Thiol-Induced Variation in Aldose Reductase Activity 1993 ·Advances in experimental medicine and biology ·Kurt M. Bohren,Kenneth H. Gabbay	15
15	Two Unrelated Patients with Familial Hyperproinsulinemia due to a Mutation Substituting Histidine for Arginine at Position 65 in the Proinsulin Molecule: Identification of the Mutation by Direct Sequencing of Genomic Deoxyribonucleic Acid Amplified by Polymerase Chain Reaction 1990 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown),Nina Raben,Takashi Kadowaki,Alessandro Cama,Domenico Accili,Kenneth H. Gabbay,John A. Merenich,Simeon I. Taylor,Jesse Roth	24
16	Oligonucleotide probes for HLA-DQA and DQB genes define susceptibility to Type 1 (insulin-dependent) diabetes mellitus 1988 ·Diabetologia ·David Owerbach,Sheila Gunn,(unknown),L Wible,Kenneth H. Gabbay	30
17	T-cell-defined DR4 subtypes as markers for type 1 diabetes 1988 ·Human Immunology ·James R. Rowe,E.M. Mickelson,(unknown),Michael J. MacDonald,Catherine Allen,Kenneth H. Gabbay,Edmond J. Yunis,Michael J. Sheehy	15
18	Formation of biologically active peptides 1980 ·Proceedings of the Royal Society of London. Series B, Biological sciences ·Donald F. Steiner,Christoph Patzelt,Shu Jin Chan,Paul Quinn,Howard S. Tager,David A. Nielsen,Åke Lernmark,B E Noyes,K Agarwal,Kenneth H. Gabbay,Arthur H. Rubenstein	10
19	The development and regulation of the endocrine pancreas 1977 ·The Journal of Pediatrics ·Harry J. Hirsch,Sherry Loo,Kenneth H. Gabbay	5
20	The effect of an aldose reductase inhibitor on the galactose-exposed rabbit lens 1968 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Jin H. Kinoshita,D. Dvornik,(unknown),Kenneth H. Gabbay	78

About Kenneth H. Gabbay

Kenneth H. Gabbay is a scholar working on Cell Biology, Endocrinology, Diabetes and Metabolism and Pediatrics, Perinatology and Child Health, having authored 116 papers that have together received 11.0k indexed citations. Recurring topics across this work include Aldose Reductase and Taurine (46 papers), Pancreatic function and diabetes (30 papers) and Prenatal Substance Exposure Effects (21 papers). The work is most often cited by research in Cell Biology (4.0k citations), Endocrinology, Diabetes and Metabolism (3.4k citations) and Clinical Biochemistry (1.1k citations). Kenneth H. Gabbay has collaborated with scholars based in United States, Switzerland and Sweden. Frequent co-authors include Kurt M. Bohren, Paul M. Gallop, H. Franklin Bunn, David Owerbach, Christine Balko, Ralf Steinmetz, David N. Haney, Bryant P. Bullock, L Merola and Bendicht Wermuth. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact